Your Host
Larry Cohen

Larry Cohen is the host of Ringler Radio and is the head of Ringler Associates operations in the Northeast....

Episode Notes

Hormone replacement therapy, also known as HRT, was prescribed to women to treat the symptoms of menopause for years. Then in 2002, a comprehensive women’s health study was published.  The study connected HRT to increasing incidences of breast cancer.  Ringler Radio host Larry Cohen turns to Attorney Ted Meadows from the Beasley Allen Law Firm, for more details on hormone replacement therapy,  ongoing litigation and the various plaintiffs involved in these cases.

Visit Ringler Associates to contact a consultant in your area about structured settlements.

Newsletter

Notify me when there’s a new episode!

Episode Details
Published: June 25, 2012
Podcast: Ringler Radio
Podcast
Ringler Radio
Ringler Radio

Ringler Radio presents an unprecedented analysis of the latest news impacting the structured settlement profession.

Listen & Subscribe
Recent Episodes
01/07/20
Structured Installment Sales

Larry Cohen and guest and Ringler colleague, Phillip Krause discuss the benefits and advantages of going with a structured installment sale, and the reasons...

12/09/19
Inside the Vegas Shootings Settlement

Mo Aziz discusses the settlement of the vegas shooting, the liability and negligence of MGM, and how this human tragedy led to a relatively...

11/18/19
Technology in the Alternative Dispute Resolution Arena

Hon. Elizabeth Bonina takes a look at the use of technology in the Alternative Dispute Resolution arena and discusses how technology is improving the...

11/04/19
Inside the Controversial Purdue Pharma Settlement

Jonathan Novak discuss Purdue Pharma’s bankruptcy filing and whether the remaining 25 states will agree to a settlement or take their fight to the courts.

10/24/19
Labor Shifts Impact on the Workers’ Compensation Industry

Larry Cohen and Alan Pierce take a look at the history of workers’ comp and discuss technology’s impact on the workplace.

09/23/19
JUUL Litigation

Joseph VanZandt discusses the recent news on sales, marketing, and labeling against JUUL, and how they've failed to warn off the products’ with high...